The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IMpassion130: a Phase III randomized trial of atezolizumab with nab-paclitaxel for first-line treatment of patients with metastatic triple-negative breast cancer (mTNBC).
 
Leisha A. Emens
Honoraria - Amgen; AstraZeneca; Celgene; Syndax; Vaccinex
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Syndax; Vaccinex
Research Funding - Amplimmune; AstraZeneca; EMD Serono; Maxcyte; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Aduco Biotech
Other Relationship - FDA
 
Sylvia Adams
Research Funding - Genentech; Merck
 
Sherene Loi
Research Funding - Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - PI3K pathway gene signature granted by the European and US patent offices
 
Andreas Schneeweiss
Honoraria - Celgene; Roche
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene; Roche/Genentech
 
Hope S. Rugo
Honoraria - Genomic Health
Speakers' Bureau - Genomic Health
Research Funding - Celsion (Inst); Celsion (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Mylan; Nektar; Novartis; OBI Pharma; Roche/Genentech
 
Eric P. Winer
Honoraria - Verastem
Consulting or Advisory Role - Genentech/Roche; Novartis; Verastem
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Carlos H. Barrios
Honoraria - Boehringer Ingelheim; Eisai; GlaxoSmithKline; Novartis; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Astellas Pharma; Boehringer Ingelheim; Eisai; GlaxoSmithKline; Novartis; Pfizer; Roche/Genentech
Research Funding - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Biomarin; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Eisai; GlaxoSmithKline; GlaxoSmithKline; Lilly; Merck; Merrimack; Mylan; Novartis; Pfizer; Roche/Genentech; Sanofi; Taiho Pharmaceutical
 
Veronique Dieras
Consulting or Advisory Role - Eisai; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Novartis; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche
 
Juan de la Haba-Rodriguez
Honoraria - Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
Research Funding - Roche Pharma AG
 
Luca Gianni
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; Genomic Health; GlaxoSmithKline; Merck Sharp & Dohme; Pfizer; Roche; Sanofi; Synaffix; Synthon; Taiho Pharmaceutical; Tiziana Life Sciences
Patents, Royalties, Other Intellectual Property - Roche
 
Stephen Y. Chui
Employment - Genentech
Research Funding - Genentech
 
Peter Schmid
Honoraria - AstraZeneca; Pfizer
Consulting or Advisory Role - Roche/Genentech (I)
Research Funding - Astellas Pharma; AstraZeneca; Genentech; OncoGenex